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Background: Older women have lower breast cancer surgery rates than younger women. UK policy states that differences in
cancer treatment by age can only be justified by patient choice or poor health.
Methods: We investigate whether lack of surgery for older patients is explained by patient choice/poor health in a prospective
cohort study of 800 women agedX70 years diagnosed with operable (stage 1–3a) breast cancer at 22 English breast cancer units
in 2010–2013. Data collection: interviews and case note review. Outcome measure: surgery for operable (stage 1–3a) breast cancer
o90 days of diagnosis. Logistic regression adjusts for age, health measures, tumour characteristics, socio-demographics and
patient’s/surgeon’s perceived responsibility for treatment decisions.
Results: In the univariable analyses, increasing age predicts not undergoing surgery from the age of 75 years, compared with
70–74-year-olds. Adjusting for health measures and choice, only women agedX85 years have reduced odds of surgery (OR 0.18,
95% CI: 0.07–0.44). Each point increase in Activities of Daily Living score (worsening functional status) reduced the odds of surgery
by over a fifth (OR 0.23, 95% CI: 0.15–0.35). Patient’s role in the treatment decisions made no difference to whether they received
surgery or not; those who were active/collaborative were as likely to get surgery as those who were passive, that is, left the
decision up to the surgeon.
Conclusion: Lower surgery rates, among older women with breast cancer, are unlikely to be due to patients actively opting out of
having this treatment. However, poorer health explains the difference in surgery between 75–84-year-olds and younger women.
Lack of surgery for women aged X85 years persists even when health and patient choice are adjusted for.
Older women experience higher incidence and worse survival for
breast cancer compared with younger women. Incidence doubles
from 202 out of 100 000 for women aged 45–49 to 409 out of
100 000 for those aged X85 years (England 2009) (ONS, Office of
National Statistics, 2011). Relative five year breast cancer survival
decreases with age from 89% for 40–49-year-olds to 69% for
women aged X80 years, a drop not seen in the United States and
Western European countries (Coleman et al, 2011; Cancer
Research UK, 2012). The King’s Fund indicates that improved
management of older cancer patients could increase cancer survival
in England (Foot and Harrison, 2011), and it has been estimated
that more than 14 000 cancer deaths could be avoided each year in
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the UK for people aged X75 years if our mortality rates matched
those of the USA (Moller et al, 2011).
Previous studies demonstrate significant and substantial
differences in the management of older women with breast
cancer compared with younger women (Bouchardy et al, 2007;
Louwman et al, 2007). Older women are less likely to be managed
in line with the treatment guidelines. Specifically, they are less
likely to undergo primary surgery and are also less likely to
have follow-up adjuvant treatments such as radiotherapy and
chemotherapy (Wyld et al, 2004; Giordano et al, 2005; Naeim
et al, 2006; Lavelle et al, 2007b). Around 60% of women aged
X80 years in England do not have surgery for breast cancer
compared with o10% of younger age groups (Lavelle et al,
2007a,b, 2012; Lawrence et al, 2011).
There are many reasons why treatment could vary with age, but
UK national cancer strategy has identified ‘patient choice’ and
‘poor health’ as the only ‘acceptable’ reasons for older breast cancer
patients not receiving clinically appropriate treatment (DH,
Department of Health, 2007, 2011). A systematic review comparing
surgery plus endocrine therapy with endocrine alone in women
aged X70 years concludes that surgery should only be omitted in
women who are ‘unfit for, or refuse, surgery’ (Hind et al, 2007,
p 1029). A recent UK Parliamentary Inquiry into older age and
breast cancer states that ‘the pressing question is whether the
reduced level of treatment observed in older breast cancer patients
is justified’ and highlights that adjusting for patients’ co-
morbidities and frailty would help establish whether older people
with breast cancer are being ‘inappropriately undertreated’ (APPGBC,
All Party Parliamentary Group on Breast Cancer, 2013, p 17).
Our previous studies suggest that older women in the UK are
receiving non-standard treatment for breast cancer for reasons
other than having poorer general health (Lavelle et al, 2007b,
2012), as defined by co-morbidity and increasing dependence in
Activities of Daily Living (ADL) (functional status). Patients aged
X80 years, attending breast cancer units in Greater Manchester
between 2002–2003, had 44 times the odds of not receiving surgery
for operable breast cancer compared with patients aged 65–79
years, controlling for co-morbidity and functional status (Lavelle
et al, 2007a). Several national policies, guidelines (DH, Department
of Health, 2000, 2007, 2011) and initiatives (MacMillan Cancer
Support, Age UK and the Department of Health, 2012) have
specifically addressed the issue of access to treatment for older
cancer patients. This may well have increased surgical rates among
older cancer patients over the last decade. Using routine
registration data we recently investigated over 23 000 women aged
X65 years, registered with breast cancer in Northern Yorkshire
and West Midlands, and showed surgery rates rose from 67.4% in
1997–1999 to 75.1% in 2003–2005 (Lavelle et al, 2012). After
adjustment for co-morbidity, older age still predicted lack of
surgery. Compared with 65–69-year-olds, the odds of surgery
decreased from 0.74 (95% CI: 0.66–0.83) for 70–74-year-olds to
0.13 (95% CI: 0.11–0.14) for women agedX85 years. However, co-
morbidity is likely to be underestimated as the routine data sources
are limited to inpatient stays only. Moreover, no data on wider
measures of health such as patient frailty or functional status are
routinely collected in the UK, so could not be included. Functional
status has been shown to vary independently from co-morbidity
(Extermann et al, 1998) and has been found to account for some of
the difference in surgical treatment between younger and older
breast cancer patients (Lavelle et al, 2007a).
One explanation for differences in the treatment is that older
women may choose non-standard treatment (e.g., decline surgery).
No measure of patient choice was adjusted for in these previous
UK studies. Tang et al (2011) found that of women aged X70
years, diagnosed with early stage breast cancer in Nottingham
(England), who were offered a choice between surgery or treatment
with hormone therapy, 58.9% did not have surgery. However,
no adjustment was made for age and health in multivariable analysis.
The residual variation in access to surgery, not explained by choice
and health, could therefore not be estimated. Taking account of
patient preference in multivariate models has been attempted in
two US studies (Silliman et al, 1997; Mandelblatt et al, 2000). Both
adjusted for physical health status as measured by the Short Form-
36 (Ware et al, 2002) and whether treatment options had been
offered/discussed. However, older age remained the strongest
predictor of not receiving standard treatment, after adjusting for
these measures of patient health and choice. The generalisability of
these results to the UK is limited by differences between the health
care systems and survival rates (Coleman et al, 2008). Moreover,
even when a treatment choice is offered, the patient could defer to
the doctor’s advice. There is evidence that older women with breast
cancer prefer (and are more likely) to do this (Degner et al, 1997),
suggesting that non-standard management of older women is more
likely to be the result of the doctor’s rather than the patient’s
decision. This needs to be tested in a study in which perceptions of
responsibility for the treatment decision for non-standard manage-
ment are also measured and adjusted for.
The current study therefore investigates the extent to which the
lack of surgery for older patients is justified by patient choice or
poor health and, thereby, whether (and if so the extent to which)
‘inappropriate undertreatment’ (as defined by national policy)
occurs among older breast cancer patients in the UK.
MATERIALS AND METHODS
Study design. This is a prospective, cohort study of a consecutive
series of women diagnosed with operable (stage 1–3a) breast
cancer attending 22 breast cancer units predominantly in North-
west England, over a period of 33 months. Data on patient
preferences, tumour characteristics, general health and treatment
were collected by patient interviews and case note review. The
primary outcome measure is primary surgery for operable (stage
1–3a) breast cancer within 3 months of diagnosis. Explanatory
variables adjusted for include age, measures of health, patient
choice, tumour characteristics, demographics and hospital resources.
Measures of health. Reflecting WHO’s definition of health as
‘a state of complete physical, mental and social well-being and not
merely the absence of disease and infirmity’ (WHO, 1948), a range
of health measures, representing patient’s functional/health status
and Health Related Quality of Life (HRQoL) in addition to co-
morbidity and other clinical measures, were considered. Measures
have primarily been selected based on ease of administration,
validity, reliability, acceptability to older people (Sturgis et al, 2001;
Haywood et al, 2004), and prediction of non-standard manage-
ment (Lavelle et al, 2007a) and/or treatment outcomes (Audisio
et al, 2005). Measures include: Elderly Population Health Status
Survey’s (ELPHS) ADL (Sharples et al, 2000) functional status
measure, Short Form-12 (SF-12) (Ware et al, 2002) health status
measure, European Organisation for Research and Treatment of
Cancer EORTC-C30 measure of HRQoL (Osoba et al, 1997),
Eastern Co-operative Oncology Group-Performance Status (Oken
et al, 1982), 6 item Cognitive Impairment Test (6CIT) (Brooke and
Bullock, 1999), smoking status, body mass index (Bertin et al, 1998;
Sorensen et al, 2002) and Charlson Index of Co-morbidity
(Charlson et al, 1987).
Patient choice. The Control Preferences Scale (CPS) has a
component Perception Scale (Degner et al, 1997; Janz et al,
2004), which we used to examine the extent to which older patients
were given and made the choice of whether or not to have surgery
from the perspective of both the patients and their surgeons. The
CPS Perception Scale measures perceptions of responsibility for the
treatment decision (see Table 1), presenting the patient/surgeon
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with five corresponding response alternatives along a continuum,
from the patient to the doctor solely making the treatment
decision. The Patient Perception Scale is used to elicit patients’
perceptions of who made the decision of whether or not to have
surgery. In a subgroup, we also use the Physician Perception Scale
to investigate surgeons’ perceptions of the same decision for the
same consultations (Janz et al, 2004). The patient can then be
classified as passive (i.e., surgeon made decision) vs collaborative/
active (i.e., patient shared in or made decision). The scale can only
be applied to consultations where a treatment option has been
considered. An additional category of ‘not discussed’ is therefore
also included.
Tumour characteristics. Pre-treatment assessments of tumour
characteristics, tumour size, stage, nodal and steroid receptor status
were recorded based on clinical, imaging and fine needle/core
biopsy assessments (cTNM (UICC, 2009)).
Socio-demographics. Socio-economic class is measured using the
National Statistics Socio-Economic Classification (ONS, Office of
National Statistics, 2013) and based on the main occupation pre-
retirement if retired and the highest classification if the participant
was married or living with a partner. Ethnicity was recorded based
on the census classification categories (ONS, Office of National
Statistics, 2010).
Study population. Of the 22 breast cancer units in the study 19
are based in the North West of England, 2 in London and 1 in the
Midlands. Surgeons’ views of the surgical treatment decisions were
also collected after each relevant consultation in a subgroup of 12
breast cancer units only, mainly based in Greater Manchester. The
restriction of this subset was largely due to the feasibility of
obtaining surgeons’ views within a manageable geographical area.
Inclusion criteria
Women. Men were not included as o1% of all invasive breast
cancer occurs in men (ONS, Office of National Statistics, 2011) and
surgical management differs (SIGN, Scottish Intercollegiate
Guidelines Network, 2005; ABS at BASO, Association of Breast
Surgeons at British Association of Surgical Oncologists, 2009;
NICE, National Institute for Clinical Excellence, 2009).
Aged X70 years. Previous studies suggest that odds of not
receiving surgery significantly increase from age 70 (Lavelle et al,
2012). Women aged 70–74 years are included as a reference group.
Diagnosed with a new episode of operable invasive breast cancer
(stage 1–3a). Carcinoma in situ, stage 3b, metastatic and recurrent
breast cancers are not included as the standards for operable breast
cancer do not apply (SIGN, Scottish Intercollegiate Guidelines
Network, 2005; ABS at BASO, Association of Breast Surgeons at
British Association of Surgical Oncologists, 2009; NICE, National
Institute for Clinical Excellence, 2009).
Screening and accrual. The study was phased in at 16 sites from
July 2010 to October 2010 and 6 sites joined the study later.
Recruitment ended in sites from October 2012 to April 2013. At 10
sites we recruited patients from age 65 years to take part in a
further study of diagnostic tests and follow-up treatments. Apart
from the lower age limit, the studies are identical and we include
patients aged X70 in this paper. During the recruitment period
2631 patients were screened for eligibility, 1923 approached by the
Trust staff to take part in the study and 1004 recruited (52%).
Following initial recruitment, 200 patients were excluded
(Figure 1). For a further four patients we were unable to obtain
case notes for review, leaving 800 included patients aged X70
years.
Data collection. Eligible patients were identified at diagnosis by
Multi-Disciplinary Team meetings, clinic lists and hospital
computer systems by research nurses. A patient information pack
was given to patients in clinic and followed up by telephone call.
Patients who agreed to take part were interviewed within 30 days of
diagnosis and (if they were having surgery) before surgery took
place. The interview comprised demographic variables and
measures of health as detailed above. CPS cards elicited patients’
perceived role in the surgical decision. In 12 of the 22 sites
surgeons’ perceptions (CPS) were also recorded. In these sites
following a consultation, in which the decision for surgery or not
was taken for each eligible patient, the surgeon completed the CPS
scale (Table 1). The case notes of each patient were reviewed at 3
months post-diagnosis, or later, using a proforma developed to
collect data on tumour characteristics at diagnosis, treatments
undertaken and co-morbidity. Inter-rater agreement levels for the
proforma all satisfied kappa 40.6 indicating substantial to perfect
agreement (Landis and Koch, 1977). Three per cent of case note
review proformas and 8% of patient interviews were tested for data
input errors. Error rates per data item inputted wereo0.5% so no
further data-checking was required.
Sample size. In order to test whether patients’ health and role in
the surgical treatment decision predicts surgery among women
Table 1. Control preferences scalea
Option Physician perception scaleb Patient perception scalec
A The patient made the final decision about which treatment she would receive. I made the final decision about which treatment I would receive.
B The patient made the final decision about which treatment she would receive
after seriously considering my opinion.
I made the final decision aboutd my treatment after seriously
considering my doctor’s opinion.
C I shared responsibility with the patient for making the final decision about the
treatment she would receive.
My doctor and I shared responsibility for deciding which
treatment was best for me.
D I made the final decision about which treatment the patient would receive after
seriously considering the patient’s opinion.
My doctor made the final decision about which treatment would
be used but seriously considered my opinion.
E I made the final decision about which treatment the patient would receive. My doctor made the final decision about which treatment I would
receivee.
aDegner et al (1997).
bJanz et al (2004).
cModified from Janz et al (2004).
d‘Selection of’ changed to ‘decision about’ to correspond more closely with other responses and scales.
e‘All the decisions regarding my treatment’ changed to ‘ the final decision about which treatment I would receive’ to correspond more closely with Physicians Perception Scale and to avoid
patient confusion, that is, referring to the treatment decision for surgery vs no surgery not the treatment decision for type of surgery.
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aged X70 with operable breast cancer, the recommended sample
size is determined by the number of explanatory variables included
in the logistic regression model predicting surgery in order to avoid
over-specification. For reliable modelling, logistic regression should
have at least 10 cases for each explanatory variable for both
categories of a binary dependant variable (Peduzzi et al, 1996;
Bland, 2005). The main limiting factor is therefore the number of
patients not receiving primary surgery for operable breast cancer
(17% in our previous study (Lavelle et al, 2007a) – a 1 : 4.9 ratio of
no surgery to surgery). To have at least 10 times as many cases as
variables for patients not receiving surgery, we therefore need 110
patients not receiving surgery to allow a maximum of 11
explanatory variables. This requires 539 patients receiving surgery
and thus the rule-of-thumb recommends having at least 649
patients in the final model.
Analyses. Explanatory variables were investigated in univariable
analysis using Pearson’s w2 test, Fisher’s exact test, w2 test for trend
and univariable logistic regression analyses to generate odds ratios
(two tailed with a¼ 0.05). The distribution of continuous variables
was assessed for normality using the Shapiro–Wilk W-test.
Associations between non-normal variables and surgery/age group
were investigated using the non-parametric two-sample Wilcoxon
rank sum (Mann–Whitney test) and Kruskal–Wallis equality-of-
populations rank test, respectively. Associations for parametric
variables were investigated using the two-sample t-test.
Indicators of standard management found to be significantly
associated with surgery in univariable analyses were used as
independent variables in the subsequent logistic regression
(forward stepwise). The model was built in line with our Data
Analyses Plan agreed a priori with the project’s Independent Data
Monitoring Committee modifying an approach suggested by
Hosmer and Lemeshow (2000). A base model containing explanatory
variables of primary clinical importance to the study was
constructed including age group, patient role in surgical decision
and co-morbidity (as the only measure of pre-existing disease).
The remaining explanatory variables were considered unless the
significant effect was only in the ‘missing’ category of data.
Variables were considered in three groups and added into the
model in order of importance to the primary aim of the study, that
is, health measures, tumour characteristics and then socio-
demographics. Within each group the order in which variables
were added into the model was determined by Bayesian
Information Criterion (BIC) values of each variable added into
the model individually. Variables with lower BIC values were
added in sequentially starting with the variable giving the lowest
value. At each step an individual variable’s contribution to the
model was assessed using two criteria: (1) the difference between
the model with the additional variable and the previous model
using the Likelihood Ratio Test (a.k.a. analysis of deviance) and
(2) producing a significant coefficient in the model (both at a 5%
significance level). In order to reduce the likelihood of multi-
collinearity and to ensure the number of cases in the model could
sustain the potentially high number of health measures, they were
only retained in the model if they produced both a significant
coefficient and likelihood ratio test. Tumour characteristics and
socio-demographic variables were retained if they had a significant
likelihood ratio test only. Once each group of variables had been
added variance inflation factors were checked and variables
exhibiting factors above 10 removed to prevent multicollinearity
(Kutner et al, 2004).
In order to retain sufficient number of cases to support the
subgroup analysis, which includes surgeons’ perceptions in a
nested model, all variables with non-significant coefficients were
removed from the final main model. In addition one health
measure was selected and retained as representative of the
remaining health measures. Both the main and nested models
were tested for goodness of fit (Hosmer & Lemeshow) and
discrimination (area under receiver operating characteristic curve).
Data were analysed using STATA version 12.
RESULTS
Sample characteristics. Eight hundred women were included,
of whom 83.0% (664) had surgery (95% CI: 80.4–85.6%) and 48.0%
had a Charleson co-morbidity score of X1 (95% CI: 44.5–51.5%).
Ages ranged from 34% aged 70–74 years, 30% 75–80 years, 19%
80–84 years to 17% aged X85 years (Table 2). The sample was
predominantly of professional/intermediate social class and white
ethnic group. Over half were treated at a district general hospital
rather than a university teaching hospital. The majority of
participants (62.4%) believed that the option of having surgery
(vs not having surgery) was not discussed with them. Of the 35.2%
who felt it was discussed, nearly twice as many identified
themselves as active/collaborative vs passive in making this
decision. Conversely, 62.2% of surgeons indicated that the option
of no surgery vs surgery was discussed with the patient. More than
double the proportion of surgeons identified patients as active/
collaborative in this decision (52.8%) than patients did themselves
(22.9%). Of the 480 patients for whom the surgeon CPS was not
missing, 473 had a corresponding patient CPS referring to
the same index consultation (Table 3). Of these, in 249 cases the
patient and the surgeon selected the same option regarding the
patient’s role in the surgical decision (52.6%) giving a kappa value
of 0.261, indicating fair agreement (Landis and Koch, 1977).
The majority of disagreement is due to the 123 cases (26.0%) in
which the patient felt the option of surgery vs no surgery was not
discussed but the surgeon felt that it was and that the patient was
active/collaborative in this discussion.
Number of patients screened 
n=2631 
Number of patients approached 
n=1923 
Number of patients recruited 
n=1004 
52% response rate 
Final sample 
n=800 
Excluded (204) 
- Metastatic disease (7) 
- Inoperable advanced (29) 
- Carcinoma in situ only (13) 
- Recurrent breast cancer (4) 
- Private treatment (2) 
- Died <90 days of diagnosis and pre-surgery (1) 
- Aged 65–69 (n=144) 
- No case notes available for review (4) 
Figure 1. Recruitment and retention of patients in the study.
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Just over 40% of the sample were recorded with stage I disease at
diagnosis; 58.3% were stage II or IIIa and were hence regarded as
having early operable breast cancer (SIGN, Scottish Intercollegiate
Guidelines Network, 1998) (Table 4). Over two thirds of the sample
(70.1%) had no nodal involvement recorded at diagnosis and over
half the sample had small tumours of p20mm (53.9%). The vast
majority of participants were steroid receptor positive for either
oestrogen or progesterone receptors (85.5%).
Univariable analysis. Only 57.3% of patients aged X85 years
underwent surgery for their operable breast cancer compared with
93.5% of women aged 70–74 years (Po0.001) (Table 2). The
proportion undergoing surgery was over 8% less among manual
socio-economic classes compared with professional/intermediate
participants (P¼ 0.030). Surgical rates ranged across the 22 sites
from 67.7–96.4%, but this difference was not statistically significant
(Fisher–Freeman–Halton Exact, P¼ 0.139). There was a slight
but significantly greater surgical rate in university/teaching hospitals
(87.0%) compared with district general hospitals (80.2%) (P¼ 0.012).
Participants were less likely to get surgery if they presented with
later stage (P¼ 0.003) larger (P¼ 0.003) breast tumours (Table 4).
Mean difference in tumour size was 2.99mm between patients
having surgery (21.28mm) vs not having surgery (24.27mm)
(two-sample t-test with equal variance P¼ 0.011). Participants
were more likely to have surgery if they were negative for oestrogen
and/or progesterone steroid receptors.
All of the self reported measures of health demonstrate significantly
worsening health with increasing age (Table 5). Participants agedX85
Table 2. Socio-demographics, and role in surgical decision, by surgery
Variable Category n Percent No. surgery Per cent surgery P*
Age group (years) 70–74 275 34.4 257 93.5
75–79 236 29.5 201 85.2
80–84 151 18.9 127 84.1
85þ 138 17.3 79 57.3 o0.001a
Socio-economic classification Professional 421 52.6 358 85.0
Intermediate 198 24.8 169 85.4
Manual 171 21.4 131 76.6 0.030b
Missing 10 1.3 6 60.0 0.015c
Ethnicity White 769 96.1 643 83.6
Other 18 2.3 14 77.8 0.519c
Missing 13 1.6 7 53.9 0.020c
Hospital type Teaching/Uni 330 41.3 287 87.0
District 470 58.8 377 80.2 0.012b
Patient’s view of their role in decision: Active/collab 183 22.9 124 67.8
surgery vs no surgery CPS Passive 98 12.3 64 65.3
Not discussed 499 62.4 460 92.2 o0.001b
Missing 20 2.5 16 80.0 o0.001c
Surgeon’s view of patient’s role in Active/collab 292 52.8 224 76.7
decision: surgery vs no surgery CPS Passive 52 9.4 41 78.9
(base for % n¼553)d Not discussed 136 24.6 129 94.9 o0.001b
Missing 73 13.2 59 80.8 o0.001c
Not includedd 247 na na na
Total 800 100%
Abbreviation: CPS¼Control Preferences Scale. *P-values for each variable for complete data reported first followed by data including missings if relevant.
P-values o0.05 are shown in bold.
aw2 squared test for trend.
bw2 squared Pearson.
cFisher’s exact test.
dSurgeons’ views only taken in the nested study.
Table 3. Patients’ vs surgeons’ views of patient’s role in decision to have surgery or not
Surgeon’s view of patient’s role in surgical decision
Patient’s view of their role in surgical decision Active/collaborative Passive Not discussed Total
Active/collaborative 126 8 9 143
Passive 37 11 15 63
Not discussed 123 32 112 267
Total 286 51 136 473
Agreement¼ 52.6%, Kappa¼ 0.261, Po0.001. Agreed values shown in bold italics.
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years were more likely to have difficultly or need help with ADL
(Po0.001) with over 50% of this age group, also having a ECOG
performance status of 2 or more, compared with 21–37% of
younger women (Po0.001). The proportion experiencing mild to
moderate cognitive problems according to the 6CIT screening tool
was over twice as large among women aged X85 years (30.1%)
compared with younger age groups (p14%) (Po0.001). Body
mass index reduced with age (Po0.001) and a greater proportion
of those aged over 80 years were non-smokers compared with younger
women (P¼ 0.008). There was over a 10% increase in the proportion
scoring 1 or more on the Charlson co-morbidity index: from 41.1%
of 70–74-year-olds to 52.9% of X85-year-olds (P¼ 0.016).
All measures of health were significantly associated with receipt
of surgery (Table 5), with poorer health decreasing the likelihood
of undergoing surgery. Over two thirds of those not undergoing
surgery had a co-morbidity score of 1 or more compared with
44.0% of surgical patients. Those not receiving surgery were also
more likely to need help with ADL (Po0.001) with 63.4% of these
non-surgical patients having a ECOG performance status score of 2
or more compared with 26.4% of women having surgery
(Po0.001). Non-surgical patients also had a slightly lower body
mass index (P¼ 0.006) and were more likely to smoke (P¼ 0.007).
Multivariable analysis. A logistic regression analysis was carried
out to investigate whether age is a predictor of primary surgery for
operable breast cancer. There was no significant difference between
the observed and values predicted by the final model (goodness
of fit test w2 (Hosmer–Lemeshow)¼ 5.88: d.f.¼ 8; P¼ 0.661)
and model discrimination (AUC¼ 0.871) considered excellent
(Hosmer and Lemeshow, 2000). The results of the univariable
and main multivariable regression model are shown in Table 6.
In univariable analysis, the odds of receiving surgery diminished
substantially with increasing age, for all age groups with women
aged 75–79 years having 0.40 (95% CI: 0.22–0.73) the odds of
surgery compared with women aged 70–74 years. After controlling
for the effect of patient choice, health and tumour characteristics
only the oldest age group had significantly reduced odds of surgery
with women agedX85 years having just over one fifth of the odds
of receiving surgery compared with 70–74-year-olds (OR 0.21, 95%
CI: 0.10–4.46). Women perceiving themselves as passive in the
decision of whether or not to have surgery had the same chance of
having surgery as women adopting an active role. However, those
reporting that the choice between surgery and no surgery was not
discussed with them had over three and a half times the odds of
having surgery compared with women who said this option was
discussed (OR 3.54, 95% CI: 1.97–6.37). Although co-morbidity
had a significant effect in the univariable analyses, once other
health measures were adjusted for, the effect of co-morbidity lost
significance. Conversely, EORTC quality of life measure, ELPHS
ADL functional status measure and smoking status produced
significant effects in the main model with poorer health predicting
lack of surgery. For example, for each point increase on the 1–4
ADL scale, indicating poorer functional status/decreasing inde-
pendence, the odds of surgery reduce by over a third (OR 0.36, 95%
CI: 0.24–0.55). Also non-smokers have over two and a half times
the odds of undergoing surgery compared with smokers (OR 2.60,
95% CI: 1.18–5.73). The tumour characteristics of oestrogen/
progesterone steroid receptor positivity and tumour size showed a
significant effect in the univariable analyses, but this did not
remain once the other explanatory variables were adjusted for.
Surgeon’s perception of patient role in the decision of whether
or not to have surgery was significant in the univariable analyses
Table 4. Tumour characteristics at diagnosis by surgery
Variable Category n Percent No. surgery Percent surgery P*
Stage I 334 41.8 293 87.7
II and IIIaa 466 58.3 371 79.6 0.003c
Nodes involved Yes 239 29.9 197 82.4
No/NR 561 70.1 467 83.2 0.778c
Tumour size p20mm 431 53.9 374 86.8
420p50mm 329 41.1 260 79.0
450mm 22 2.8 15 68.2 0.003d
Missing 18 2.3 15 83.3 0.007d
Grade 1 138 17.3 112 81.2
2 428 53.5 348 81.3
3 168 21.0 145 86.3 0.213b
Missing 66 8.3 59 89.4 0.220c
Oestrogen receptor ER status Positive 667 84.6 549 81.1
Negative 85 10.6 79 92.9 0.006d
Missing 38 4.8 36 94.7 0.002d
Progesterone receptor PR status Positive 523 65.4 417 79.7
Negative 188 23.5 166 88.3 0.008d
Missing 89 11.1 81 91.0 0.002d
ER or PR positive Yes 684 85.5 555 81.1
No 72 9.0 68 94.4 0.003d
Missing 44 5.5 41 93.2 0.002d
Total 800 100%
Abbreviations: ER¼oestrogen receptor; PR¼progesterone receptor; NR¼not reported. P-valueso0.05 are shown in bold. *P-values for each variable for complete data reported first followed by
data including missings if relevant.
aIncludes 17 patients with stage IIIa.
bw2 squared test for trend.
cw2 squared Pearson.
dFisher’s exact test.
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(Table 7). Similar to the patients’ perception measure, if surgeons
perceived that the option of surgery (vs no surgery) was not
discussed, the patient had over five and a half times the odds of
having surgery (OR 5.59, 95% CI: 2.49–12.55). However, after
adjusting for the other explanatory variables, this effect failed to
retain significance. Owing to the smaller sample size available to
this subgroup analyses, all non-significant variables were dropped
and, of the health measures, only ELPHS ADL was retained as this
produced the strongest effect in the main model. The addition of
surgeons’ perceptions in this nested model does not alter much the
effect of age on chance of surgery. After adjusting for patient
choice, as well as functional health status, women aged X85 years
still have around a fifth of the odds of surgery compared with
70–74-year-olds (OR 0.18, 95% CI: 0.07–0.44).
DISCUSSION
In this prospective cohort study of 800 women aged X70 years
diagnosed with invasive operable breast cancer, women aged X85
years were less likely to have surgery adjusting for the effects of
patient health and choice. The reduction in surgical rates with
increasing age demonstrated in this study is in broad agreement
with previous studies both in the UK (Golledge et al, 2000; Wyld
et al, 2004; Lavelle et al, 2007a,b, 2012) and elsewhere (Hillner et al,
1996; Giordano et al, 2005; Naeim et al, 2006). However, previous
studies reporting unadjusted surgical rates demonstrate reduced
odds of surgery from the age of 70 years and older (Bastiaannet
et al, 2010; Lawrence et al, 2011; Tang et al, 2011); a pattern also
demonstrated in our unadjusted odds reported here. Once patient
health and choice were adjusted for, both the location and size of
effect changed. Although the pattern of decreased odds of surgery
with increasing age remained, only the oldest women aged X85
years retained significantly reduced odds of surgery; around a fifth
for adjusted odds compared with those aged 70–74-year-olds vs a
tenth for unadjusted odds. However, neither patient health nor
choice accounts for the lack of surgery for the oldest women aged
X85 years.
This reduction in effect size, to the point of non-significance, for
75–84-year-olds appears to be largely driven by adjustment for
measures of health rather than patient choice. In the main and
Table 5. Health measures by age and surgery
Measure Age (years) Scores P* Surgery Scores P*
ELPHS ADL self report 1–4 inc¼worse 70–74 1.44 (1.37–1.51) Yes 1.57 (1.52–1.62)
75–79 1.72 (1.63–1.81) No 2.42 (2.30–2.55) o0.001a
80–84 1.77 (1.66–1.87)
85þ 2.20 (2.07–2.32) o0.001b
SF12 PCS self report 1–100 inc¼better 70–74 46.83 (45.38–48.28) Yes 45.02 (44.10–45.95)
75–79 42.59 (40.84–44.33) No 32.43 (30.15–34.70) o0.001a
80–84 41.47 (39.53–43.40)
85þ 37.88 (35.63–40.13) o0.001b
EORTC QLQ self report 1–100 inc¼better 70–74 72.59 (70.12–75.05) Yes 69.83 (68.13–71.52)
75–79 63.93 (60.41–67.44) No 48.23 (43.67–52.79) o0.001a
80–84 63.41 (59.74–67.09)
85þ 61.89 (57.75–66.04) o0.001b
PS self report 0–4 categories, inc¼worse, %41 70–74 20.97 (16.06–25.89) Yes 26.36 (22.95–29.77)
75–79 31.90 (25.85–37.94) No 63.36 (55.00–71.72) o0.001c
80–84 36.99 (29.06–44.91)
85þ 52.67 (44.01–61.34) o0.001d
6CIT (0–28) inc¼worse, %47 i.e., mild/mod cog impair 70–74 10.89 (7.06–14.73) Yes 12.79 (10.10–15.49)
75–79 12.02 (7.56–16.48) No 25.00 (16.54–33.46) 0.002c
80–84 13.85 (7.83–19.86)
85þ 30.10 (21.09–39.11) o0.001d
Body mass index 70–74 28.46 (27.76–29.17) Yes 27.90 (27.48–28.31)
75–79 28.25 (27.49–29.00) No 26.60 (25.50–27.69) 0.006a
80–84 27.29 (26.56–28.02)
85þ 25.54 (24.70–26.38) o0.001b
Smoking status (% non-smokers) 70–74 87.96 (84.08–91.83) Yes 92.15 (90.09–94.20)
75–79 88.94 (84.90–92.98) No 84.09 (77.77–90.41) 0.007c
80–84 96.67 (93.76–99.57)
85þ 93.33 (89.07–97.60) 0.008d
Charlson co-morbidity, %X1 70–74 41.09 (35.24–46.94) Yes 43.98 (40.19–47.76)
75–79 51.27 (44.85–57.69) No 67.65 (59.68–75.61) o0.001c
80–84 50.99 (42.93–59.06)
85þ 52.90 (44.47–61.33) 0.016d
Abbreviations: 6CIT¼ 6-Item Cognitive Impairment Test (scale 0–28: increase indicates worse cognitive impairment, 0–7 indicates normal); ECOG-PS¼Eastern Co-operative Oncology Group –
Performance Status (0–5 categories indicate decreasing functional status); ELPHS ADL¼Elderly Population Health Status Survey’s Activity of Daily Living (scale 1–4: increase indicates worse
functional status); EORTC QLQ-C30¼European Organization for Research on Treatment of Cancer Quality of Life Questionnaire (version 3) Global Quality of Life scale 1–100 (increase indicates
better health related quality of life); SF-12¼ Short Form-12 Physical Component Summary (scale 1–100: increase indicates better health status). Values for scores are mean (95% confidence
interval) unless indicated otherwise.
aMann–Whitney.
bKruskal–Wallis w2.
cFisher’s exact.
dw2 for trend.
*All P-values are o0.05.
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nested models only whether or not the patient perceived the
surgical treatment decision was discussed remained significant.
Measuring and adjusting for patient choice in terms of responsi-
bility for treatment decisions builds on previous research, which
either simply records whether a treatment option was offered or
whether ‘patient choice’ is listed as a reason for lack of treatment in
case notes. As Hamaker et al (2013), point out this latter approach
is flawed because ‘what is stated to be the patient’s preference could
in fact be a reflection of the physician’s preference’ (p550). In our
prospective cohort we measure responsibility for the surgical
treatment decision from both the surgeon’s and the patient’s
perspective using the previously validated CPS (Degner et al, 1997).
On the basis of responses to the CPS there is no evidence that there
was active choice not to have surgery among those who did not
have surgery. These findings suggest that the lack of surgery for the
oldest patients is not due to them actively opting out of having this
treatment. However, actually having the discussion about not
having/having surgery is associated with reduced likelihood of
receiving surgery. Tang et al (2011) also found that 58.9% (66 out
of 112) breast cancer patients aged 470 years did not go on to
have surgery after being offered a choice of this or treatment with
hormone therapy. A likely explanation for this is that the option of
not having surgery is only offered/discussed if there are concerns
about the patient undergoing surgery.
Among the measures of heath, the strongest predictor of
undergoing surgery was the functional status measure of ADL.
Activities of Daily Living has been shown in previous studies to
predict access to and outcomes from surgery in terms of
complications and HRQoL (Extermann and Hurria, 2007;
Lavelle et al, 2007a; Audisio et al, 2008; Pal et al, 2010). ADL
measures the ability to function independently in everyday life
and is a consistent component of the Comprehensive Geriatric
Assessment; a battery of varying health status and functional tests
recommended by the International Society for Geriatric Oncology
as an essential element of treatment decision making for older
cancer patients (Biganzoli et al, 2012). The European Organisation
for Research and Treatment of Cancer also states that ‘main-
tenance of function and independence should be one of the major
principles of cancer management in the elderly’ (Pallis et al, 2010).
The strength of ADL’s prediction of having surgery, both in this
and previous studies, suggest that maintenance of independence is
a pivotal consideration for older patients contemplating surgery.
The ECOG PS scale also measures functional status and has
been shown to predict surgical outcomes for older cancer patients
(Audisio et al, 2008). With the added attraction of brevity (5 items
vs 18 in the ELPHS ADL), it is collected by some NHS breast care
teams as part of the Cancer Outcomes and Services Dataset (NCIN,
National Cancer Intelligence Network, 2013). However, although
ECOG PS was associated with surgery in the univariable analyses,
its effect lost significance once ELPHS ADL along with other
measures of health were adjusted for. Previous studies suggest that
ECOG PS may lack sensitivity as although 70–80% of older adults
with cancer present with an ECOG PS of 0–1 (indicating at least
capable of all basic self-care), greater than half require assistance
Table 6. Multivariable (main) logistic regression of receiving primary surgery (vs not receiving primary surgery) (n¼ 674)
Variablea
Unadjusted odds
ratio 95% CI P-value*
Adjusted odds
ratiob 95% CI P-value*
Age group
70–74 (ref) — — (ref) — —
75–79 0.40 0.22–0.73 0.003 0.69 0.32–1.50 0.354
80–84 0.37 0.19–0.71 0.003 0.54 0.24–1.20 0.131
85þ 0.09 0.05–0.17 o0.001 0.21 0.10–0.46 o0.001
Patient’s views on role CPS
Active/collab (ref) — — (ref) — —
Passive 0.90 0.53–1.50 0.677 0.89 0.44–1.81 0.750
Not discussed 5.61 3.58–8.81 o0.001 3.54 1.97–6.37 o0.001
Co-morbidity
0 (ref) — — (ref) — —
1þ 0.38 0.25–0.55 o0.001 0.61 0.36–1.05 0.075
EORTC QLQ 1–100 scale inc¼better 1.04 1.03–1.05 o0.001 1.02 1.01–1.03 0.005
ELPHS ADL 1–4 scale inc¼worse 0.20 0.15–0.27 o0.001 0.36 0.24–0.55 o0.001
Smoking
Smoker (ref) — — (ref) — —
Non-smoker 2.22 1.29–3.83 0.004 2.60 1.18–5.73 0.018
ER or PR
Positive (ref) — — (ref) — —
Negative 3.95 1.42–11.03 0.009 2.82 0.86–9.25 0.086
Tumour size (mm) 0.98 0.97–1.00 0.013 1.00 0.98–1.02 0.695
Abbreviations: CI¼ confidence interval; CPS¼Control Preferences Scale; ELPHS ADL¼Elderly Population Health Status Survey’s Activity of Daily Living; EORTC QLQ¼European Organization
for Research on Treatment of Cancer Quality of Life Questionnaire; ER¼oestrogen receptor; PR¼progesterone receptor.
aHealth measures 6CIT, BMI and ECOG performance status were not included as there was no significant effect in the initial multivariable model. SF12 PCS was removed as it produced
VIFs410. Tumour stage, nodal status, socio-economic classification and type of hospital treated at were removed as they did not significantly improve the fit of the model.
bAdjusted for all other variables in the table. All variance inflation factorso10. Goodness of fit test w2 Hosmer–Lemeshow¼ 5.88: d.f.¼ 8; P¼ 0.661. Area under receiver operator characteristics
curve¼ 0.871. *P-values o0.05 are shown in bold.
BRITISH JOURNAL OF CANCER Breast surgery and older patients’ choice/health
580 www.bjcancer.com |DOI:10.1038/bjc.2013.734
with the more advanced/instrumental ADLs such as housework,
meal preparation and shopping (Extermann, 2000; Pal et al, 2010).
ADL therefore is more likely to have sufficient sensitivity
to identify patients on the threshold of needing additional help
to maintain independence. At the point of making the decision to
have surgery or not, this may enable post-surgical-care packages to
be put in place pre-operatively if necessary.
Although co-morbidity was associated with surgery in univari-
able analyses, its effect lost significance in the main multivariable
model adjusting for other measures of health. Co-morbidity has
been found to predict lack of treatment in several previous studies
of older women with breast cancer (Ballard-Barbash et al, 1996;
He´rbert-Croteau et al, 1999; Giordano et al, 2005; Naeim et al,
2006; Lavelle et al, 2012). However, this is by no means a universal
finding (Hillner et al, 1996; Silliman et al, 1997; Mandelblatt et al,
2000; Lavelle et al, 2007a), particularly in studies, which also
adjusted for measures of functional/health status (Silliman et al,
1997; Mandelblatt et al, 2000; Lavelle et al, 2007a). This suggests
that measures of functional/health status may have a stronger
bearing on treatment decision making than co-morbidity for older
breast cancer patients. This may particularly be the case for long
standing chronic co-morbidities, such as diabetes or asthma, which
may be well managed and therefore have little impact on everyday
function or indeed the decision to have surgery for breast cancer
or not.
There is some evidence that surgical rates are improving for
older women with breast cancer in the UK. The overall surgical
rate in the study reported here (83.0% in 2010–2013) would fall in
line with the increase over time reported in our previous study
based on cancer registry data, from 67.4% in 1997–1999 to 75.1%
in 2003–2005 (Lavelle et al, 2012). Although this may, in part,
reflect improving completeness of treatment data, increasing
surgical rates over time have also been reported in national audits
(NCASP, National Clinical Audit Support Programme, 2009).
It therefore seems likely that the improved surgical rates also
demonstrate changes in practice, reflecting the guidelines that were
published and the major reorganising of cancer services over the
last 15 years (DH, Department of Health, 2000, 2007; ABS at
BASO, Association of Breast Surgeons at British Association of
Surgical Oncologists, 2009; NICE, National Institute for Clinical
Excellence, 2009; DH, Department of Health, 2011).
Compared with all breast cancers registered in England in 2011
our sample under represented women aged X85 years, that is,
26.0% nationally (ONS, Office of National Statistics, 2011)
compared with 17.3% (95% CI: 14.7–20.0%) in the study reported
here. This may be due to the exclusion of advanced/inoperable
breast cancer in our sample as older patients are more likely to
present at a later stage at which the tumour is advanced/inoperable
(Ramirez et al, 1999). However, the under-representation of older
patients is also likely to be due in part to selection bias, as
participants needed to be capable of consent and be interviewed in
order to take part in the study. Nevertheless, the proportion of
patients having a Charleson co-morbidity score ofX1 (48.0%, 95%
CI: 44.5–51.5%) is similar to that found in previous studies, which
measure breast cancer patients co-morbidity prospectively (Ring
et al, 2011; Lavelle et al, 2012). For example, Ring et al found 44.5%
(95% CI: 41.6–47.5%) of patients agedX70 years taking part in the
ATAC trial had a Charleson score of X1. Similarly, our estimates
of ADL are in line with our own (Lavelle et al, 2007a) and others
(Sharples et al, 2000) estimates in studies of older adults living in
the community. However, these previous studies are likely to be
subject to the same influence of selection bias and it is probable
that older women unable to consent/take part in an interview
would have poorer health than younger ones who can. Selection
bias towards younger and probably physically healthier women
may have limited the generalisability of the study. Yet the results
still clearly demonstrated a reduction in standard surgery for
women aged X85 years. A larger sample including older less
healthy women would have been expected to increase the
association between increasing age and non-standard management
of breast cancer.
In this study the lack of surgery for 75–84-year-olds could be
explained by differences in health status. However, once health
measures as well as patient role in treatment decision were adjusted
Table 7. Multivariable (nested) logistic regression of receiving primary surgery (vs not receiving primary surgery) adjusting for surgeons’ views on role of
patient in surgical decision (n¼ 473)
Variablea
Unadjusted odds
ratio 95% CI P-value*
Adjusted odds
ratiob 95% CI P-value*
Age group
70–74 (ref) — — (ref) — —
75–79 0.40 0.22–0.73 0.003 0.60 0.25–1.48 0.267
80–84 0.37 0.19–0.71 0.003 0.48 0.19–1.21 0.118
85þ 0.09 0.05–0.17 o0.001 0.18 0.07–0.44 o0.001
Patient’s view of role CPS
Active/collab (ref) (ref) — —
Passive 0.90 0.53–1.50 0.677 0.70 0.30–1.62 0.404
Not discussed 5.61 3.58–8.81 o0.001 2.69 1.34–5.39 0.005
Surgeon’s view of role CPS
Active/collab (ref) — — (ref) — —
Passive 1.31 0.55–2.32 0.736 0.64 0.24–1.66 0.355
Not discussed 5.59 2.49–12.55 o0.001 2.37 0.93–6.04 0.072
ELPHS ADL 1–4 scale inc¼worse 0.20 0.15–0.27 o0.001 0.23 0.15–0.35 o0.001
Abbreviations: CI¼ confidence interval; CPS¼Control Preferences Scale.
aCo-morbidity, ER/PR and tumour size were not included as there was no significant effect in the main multivariable model. ELPHS ADL was retained as it showed the strongest effect among
the health measures with significant effect in the main model. EORTC QLQ and smoking status were therefore not included.
bAdjusted for all other variables in the table. All variance inflation factorso10. Goodness of fit test w2 Hosmer–Lemeshow¼ 10.90: d.f.¼ 8; P¼ 0.208. Area under receiver operator characteristic
curve¼ 0.869. *P-values o0.05 are shown in bold.
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for, women aged X85 years were still less likely to have surgery.
Although surgical rates for older breast cancer patients appear to
be increasing, lack of surgery for women aged X85 years persists
even when health and patient choice are adjusted for. These
findings suggest that, as defined by national policy, ‘inappropriate
undertreatment’ is still occurring for this oldest age group in
the UK.
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